National Health Investors (NHI) Enterprise Value (2009 - 2026)

National Health Investors has reported Enterprise Value for 18 years, with the latest figure at -$17.1 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value rose 86.47% year-over-year to -$17.1 million; the trailing twelve-month figure through Mar 2026 stood at -$17.1 million (up 86.47% YoY), and the FY2025 full-year result was -$9.4 million, up 34.97% from the prior year.
• Enterprise Value for Q1 2026 stood at -$17.1 million, down from -$9.4 million in the prior quarter.
• The five-year high for Enterprise Value was -$1.9 million in Q1 2024, with the low at -$126.4 million in Q1 2025.
• Historically, Enterprise Value has averaged -$23.0 million across 5 years, with a median of -$9.5 million in 2022.
• Annual changes were most pronounced in 2023 — Enterprise Value soared 87.94% — and 2025, when it plunged 6444.15%.
• National Health Investors' Enterprise Value stood at -$9.5 million in 2022, then plunged by 34.07% to -$12.7 million in 2023, then dropped by 14.25% to -$14.5 million in 2024, then soared by 34.97% to -$9.4 million in 2025, then tumbled by 81.47% to -$17.1 million in 2026.
• The last three Enterprise Value figures came in at -$17.1 million (Q1 2026), -$9.4 million (Q4 2025), and -$73.1 million (Q3 2025), per Business Quant data.